[ {
  "sentence_tokens" : [ "Furthermore", ",", "MEK", "inhibitor", "exposure", "induced", "protein", "levels", "of", "pro", "apoptotic", "BIM", ",", "most", "evidently", "for", "KOPN8", ",", "while", "p53", "levels", "remained", "unaffected", "(", "Supplementary", "Figure", "5", ")", "." ],
  "event_indices" : [ 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12 ],
  "type" : "Negative_regulation",
  "polarity" : false,
  "controller_indices" : [ 2, 3, 4 ],
  "controlled_indices" : [ 7, 8, 9, 10, 11, 12 ],
  "trigger_indices" : [ 5, 6 ],
  "rule_name" : "Positive_regulation_syntax_1_verb",
  "rule" : null
}, {
  "sentence_tokens" : [ "However", ",", "we", "did", "confirm", "that", "MEK", "inhibitors", "reduced", "p-ERK", "levels", ",", "and", "induced", "apoptosis", "in", "the", "RAS-mutant", "MLL", "rearranged", "ALL", "cells", "." ],
  "event_indices" : [ 6, 7, 8, 9, 10, 11 ],
  "type" : "Negative_regulation",
  "polarity" : false,
  "controller_indices" : [ 6, 7, 8 ],
  "controlled_indices" : [ 9, 10, 11 ],
  "trigger_indices" : [ 8, 9 ],
  "rule_name" : "Negative_regulation_syntax_1_verb",
  "rule" : null
}, {
  "sentence_tokens" : [ "Interestingly", ",", "Nakanishi", "et", "al.", "previously", "demonstrated", "that", "MLL-fusion", "proteins", "can", "induce", "ERK", "phosphorylation", "through", "regulating", "EphA7", "receptor", "tyrosine", "kinase", "expression", ",", "but", "this", "was", "not", "accompanied", "by", "increased", "RAF", "or", "MEK", "phosphorylation", "[", "21", "]", "." ],
  "event_indices" : [ 8, 9, 10, 11, 12, 13, 14 ],
  "type" : "Positive_regulation",
  "polarity" : true,
  "controller_indices" : [ 8, 9, 10 ],
  "controlled_indices" : [ 12, 13, 14 ],
  "trigger_indices" : [ 11, 12 ],
  "rule_name" : "Positive_regulation_syntax_1_verb",
  "rule" : null
}, {
  "sentence_tokens" : [ "Hence", ",", "although", "MEK", "activation", "in", "presence", "of", "GDC-0973", ",", "MEK162", "or", "Selumetinib", "can", "still", "occur", ",", "the", "transduction", "of", "the", "signal", "by", "MEK", "mediated", "phosphorylation", "of", "ERK", "is", "no", "longer", "possible", ",", "as", "we", "show", "in", "Figure", "4.Recently", ",", "we", "found", "the", "presence", "of", "RAS", "mutations", "in", "MLL", "rearranged", "infant", "ALL", "cells", "correlated", "with", "prednisolone", "resistance", ",", "an", "obstacle", "in", "the", "treatment", "of", "infant", "ALL", "[", "2", ",", "3", "]", "." ],
  "event_indices" : [ 23, 24, 25, 26, 27, 28 ],
  "type" : "Positive_regulation",
  "polarity" : true,
  "controller_indices" : [ 23, 24 ],
  "controlled_indices" : [ 25, 26, 27, 28 ],
  "trigger_indices" : [ 24, 25 ],
  "rule_name" : "Positive_early_regulation",
  "rule" : null
}, {
  "sentence_tokens" : [ "Additionally", ",", "Salirasib", "and", "Vemurafenib", "did", "not", "substantially", "reduce", "cell", "viability", ",", "even", "at", "high", "concentrations", "(", ">", "10", "mu", "M", ")", "." ],
  "event_indices" : [ 2, 3, 4, 5, 6, 7, 8, 9, 10, 11 ],
  "type" : "Negative_activation",
  "polarity" : false,
  "controller_indices" : [ 2, 3 ],
  "controlled_indices" : [ 9, 10, 11 ],
  "trigger_indices" : [ 8, 9 ],
  "rule_name" : "Negative_activation_syntax_1_verb",
  "rule" : null
}, {
  "sentence_tokens" : [ "Additionally", ",", "Salirasib", "and", "Vemurafenib", "did", "not", "substantially", "reduce", "cell", "viability", ",", "even", "at", "high", "concentrations", "(", ">", "10", "mu", "M", ")", "." ],
  "event_indices" : [ 4, 5, 6, 7, 8, 9, 10, 11 ],
  "type" : "Negative_activation",
  "polarity" : false,
  "controller_indices" : [ 4, 5 ],
  "controlled_indices" : [ 9, 10, 11 ],
  "trigger_indices" : [ 8, 9 ],
  "rule_name" : "Negative_activation_syntax_1_verb",
  "rule" : null
}, {
  "sentence_tokens" : [ "Interestingly", ",", "while", "Trametinib", "by", "itself", "induced", "only", "minor", "cell", "viability", "decrease", "in", "SEM", "cells", "(", "Figure", "6B", ")", ",", "the", "combination", "of", "Trametinib", "and", "prednisolone", "greatly", "enhanced", "the", "efficacy", "of", "prednisolone", ",", "especially", "at", "higher", "concentrations", "(", "Figure", "6A", ")", "." ],
  "event_indices" : [ 3, 4, 5, 6, 7, 8, 9, 10, 11 ],
  "type" : "Negative_activation",
  "polarity" : false,
  "controller_indices" : [ 3, 4 ],
  "controlled_indices" : [ 9, 10, 11 ],
  "trigger_indices" : [ 6, 7 ],
  "rule_name" : "Positive_activation_syntax_1_verb",
  "rule" : null
}, {
  "sentence_tokens" : [ "Interestingly", ",", "Kampen", "et", "al.", "recently", "proposed", "a", "MEK", "inhibitor", "escape", "mechanism", "in", "MLL", "rearranged", "AML", ",", "which", "was", "mediated", "by", "VEGFR-2", "and", "PI3K", "signaling", ",", "and", "we", "wondered", "whether", "this", "could", "play", "a", "role", "in", "the", "MEK", "inhibitor", "resistance", "of", "our", "wildtype", "patient", "cells", "[", "5", "]", "." ],
  "event_indices" : [ 13, 14, 15, 16, 17, 18, 19, 20, 21, 22 ],
  "type" : "Positive_activation",
  "polarity" : true,
  "controller_indices" : [ 21, 22 ],
  "controlled_indices" : [ 13, 14 ],
  "trigger_indices" : [ 19, 20 ],
  "rule_name" : "Positive_activation_syntax_2_verb",
  "rule" : null
}, {
  "sentence_tokens" : [ "The", "MEK", "inhibitors", "MEK162", ",", "Selumetinib", "and", "Trametinib", "significantly", "reduce", "viability", "of", "RAS-mutant", "MLL", "rearranged", "ALL", "cells", "." ],
  "event_indices" : [ 5, 6, 7, 8, 9, 10, 11, 12, 13, 14 ],
  "type" : "Negative_activation",
  "polarity" : false,
  "controller_indices" : [ 5, 6 ],
  "controlled_indices" : [ 13, 14 ],
  "trigger_indices" : [ 9, 10 ],
  "rule_name" : "Negative_activation_syntax_1_verb",
  "rule" : null
}, {
  "sentence_tokens" : [ "The", "MEK", "inhibitors", "MEK162", ",", "Selumetinib", "and", "Trametinib", "significantly", "reduce", "viability", "of", "RAS-mutant", "MLL", "rearranged", "ALL", "cells", "." ],
  "event_indices" : [ 7, 8, 9, 10, 11, 12, 13, 14 ],
  "type" : "Negative_activation",
  "polarity" : false,
  "controller_indices" : [ 7, 8 ],
  "controlled_indices" : [ 13, 14 ],
  "trigger_indices" : [ 9, 10 ],
  "rule_name" : "Negative_activation_syntax_1_verb",
  "rule" : null
}, {
  "sentence_tokens" : [ "Additionally", ",", "no", "differences", "in", "p-ERK", "levels", "were", "found", "between", "RAS-wildtype", "and", "RAS-mutant", "samples", "(", "Figure", "3D", ")", ",", "nor", "between", "RAS-wildtype", "cells", "that", "were", "sensitive", "or", "resistant", "to", "MEK", "inhibition.In", "MLL", "rearranged", "AML", ",", "MEK", "inhibitor", "resistance", "can", "occur", "through", "activation", "of", "tyrosine", "kinase", "receptor", "(", "TKR", ")", "signaling", "(", "i.e.", "involving", "VEGFR-2", ")", "[", "5", "]", "." ],
  "event_indices" : [ 29, 30, 31, 32 ],
  "type" : "Negative_activation",
  "polarity" : false,
  "controller_indices" : [ 31, 32 ],
  "controlled_indices" : [ 29, 30 ],
  "trigger_indices" : [ 30, 31 ],
  "rule_name" : "Negative_activation_token_1_noun",
  "rule" : null
}, {
  "sentence_tokens" : [ "Moreover", ",", "RAS", "pathway", "inhibition", ",", "including", "MEK", "inhibition", ",", "was", "previously", "shown", "to", "effectively", "inhibit", "RAS-mutant", "MLL", "rearranged", "AML", "in", "vitro", "[", "5", ",", "6", "]", "." ],
  "event_indices" : [ 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18 ],
  "type" : "Positive_activation",
  "polarity" : true,
  "controller_indices" : [ 7, 8 ],
  "controlled_indices" : [ 17, 18 ],
  "trigger_indices" : [ 15, 16 ],
  "rule_name" : "Negative_activation_syntax_1_verb",
  "rule" : null
}, {
  "sentence_tokens" : [ "Recently", ",", "Irving", "et", "al.", "already", "showed", "that", "Selumetinib", "effectively", "inhibits", "leukemia", "progression", "in", "an", "in", "vivo", "model", "of", "RAS-mutant", "BCP-ALL", ",", "and", "Burgess", "et", "al.", "found", "Trametinib", "to", "prolong", "the", "survival", "of", "mice", "transplanted", "with", "NRAS", "AML", "cells", "[", "12", ",", "13", "]", "." ],
  "event_indices" : [ 8, 9, 10, 11, 12 ],
  "type" : "Negative_activation",
  "polarity" : false,
  "controller_indices" : [ 8, 9 ],
  "controlled_indices" : [ 11, 12 ],
  "trigger_indices" : [ 10, 11 ],
  "rule_name" : "Negative_activation_syntax_1_verb",
  "rule" : null
}, {
  "sentence_tokens" : [ "This", "is", "further", "supported", "by", "our", "previous", "study", "showing", "that", "in", "MLL", "rearranged", "ALL", ",", "prednisolone", "sensitization", "mediated", "by", "pan-BCL-2", "family", "inhibitors", "was", "largely", "driven", "by", "the", "up-regulation", "of", "pro", "apoptotic", "BID", "and", "BIM", "[", "27", "]", "." ],
  "event_indices" : [ 16, 17, 18, 19, 20, 21, 22 ],
  "type" : "Negative_activation",
  "polarity" : false,
  "controller_indices" : [ 19, 20, 21, 22 ],
  "controlled_indices" : [ 16, 17 ],
  "trigger_indices" : [ 17, 18 ],
  "rule_name" : "Positive_activation_syntax_2_verb",
  "rule" : null
}, {
  "sentence_tokens" : [ "This", "is", "further", "supported", "by", "our", "previous", "study", "showing", "that", "in", "MLL", "rearranged", "ALL", ",", "prednisolone", "sensitization", "mediated", "by", "pan-BCL-2", "family", "inhibitors", "was", "largely", "driven", "by", "the", "up-regulation", "of", "pro", "apoptotic", "BID", "and", "BIM", "[", "27", "]", "." ],
  "event_indices" : [ 13, 14, 15, 16, 17, 18, 19, 20, 21, 22 ],
  "type" : "Negative_activation",
  "polarity" : false,
  "controller_indices" : [ 19, 20, 21, 22 ],
  "controlled_indices" : [ 13, 14 ],
  "trigger_indices" : [ 17, 18 ],
  "rule_name" : "Positive_activation_syntax_2_verb",
  "rule" : null
}, {
  "sentence_tokens" : [ "Interestingly", ",", "while", "Trametinib", "by", "itself", "induced", "only", "minor", "cell", "viability", "decrease", "in", "SEM", "cells", "(", "Figure", "6B", ")", ",", "the", "combination", "of", "Trametinib", "and", "prednisolone", "greatly", "enhanced", "the", "efficacy", "of", "prednisolone", ",", "especially", "at", "higher", "concentrations", "(", "Figure", "6A", ")", "." ],
  "event_indices" : [ 23, 24, 25, 26, 27, 28, 29, 30, 31, 32 ],
  "type" : "Positive_activation",
  "polarity" : true,
  "controller_indices" : [ 23, 24 ],
  "controlled_indices" : [ 31, 32 ],
  "trigger_indices" : [ 27, 28 ],
  "rule_name" : "Positive_activation_syntax_1_verb",
  "rule" : null
}, {
  "sentence_tokens" : [ "Moreover", ",", "Ari", "e", "s", "et", "al.", "found", "Trametinib", "could", "restore", "prednisolone", "sensitivity", "in", "RAS-mutant", "BCP-ALL", "patient", "samples", ",", "whereas", "Rambal", "et", "al.", "showed", "that", "MEK", "activation", "reduces", "dexamethasone", "sensitivity", ",", "and", "the", "MEK", "inhibitor", "PD183452", "enhanced", "dexamethasone", "responses", "in", "ALL", "cells", "in", "a", "BIM", "dependent", "manner", "[", "24", ",", "25", "]", "." ],
  "event_indices" : [ 25, 26, 27, 28, 29 ],
  "type" : "Negative_activation",
  "polarity" : false,
  "controller_indices" : [ 25, 26 ],
  "controlled_indices" : [ 28, 29 ],
  "trigger_indices" : [ 27, 28 ],
  "rule_name" : "Negative_activation_syntax_1_verb",
  "rule" : null
}, {
  "sentence_tokens" : [ "Here", "we", "show", "that", "the", "MEK", "inhibitors", "Trametinib", ",", "Selumetinib", "and", "MEK162", "severely", "impair", "primary", "RAS-mutant", "MLL", "rearranged", "infant", "ALL", "cells", "in", "vitro", "." ],
  "event_indices" : [ 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17 ],
  "type" : "Positive_activation",
  "polarity" : true,
  "controller_indices" : [ 5, 6, 7 ],
  "controlled_indices" : [ 16, 17 ],
  "trigger_indices" : [ 13, 14 ],
  "rule_name" : "Negative_activation_syntax_1_verb",
  "rule" : null
}, {
  "sentence_tokens" : [ "Remarkably", ",", "our", "present", "data", "shows", "that", "MEK", "inhibition", "strongly", "enhances", "the", "sensitivity", "of", "both", "RAS-wildtype", "and", "RAS-mutant", "MLL", "rearranged", "ALL", "cells", "to", "prednisolone", ",", "also", "further", "exemplifying", "the", "possible", "value", "of", "MEK", "inhibitors", "for", "RAS-mutant", ",", "as", "well", "as", "RAS-wildtype", ",", "MLL", "rearranged", "infant", "ALL", "patients", "." ],
  "event_indices" : [ 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41 ],
  "type" : "Positive_activation",
  "polarity" : true,
  "controller_indices" : [ 7, 8 ],
  "controlled_indices" : [ 40, 41 ],
  "trigger_indices" : [ 10, 11 ],
  "rule_name" : "Positive_activation_syntax_1_verb",
  "rule" : null
}, {
  "sentence_tokens" : [ "Remarkably", ",", "our", "present", "data", "shows", "that", "MEK", "inhibition", "strongly", "enhances", "the", "sensitivity", "of", "both", "RAS-wildtype", "and", "RAS-mutant", "MLL", "rearranged", "ALL", "cells", "to", "prednisolone", ",", "also", "further", "exemplifying", "the", "possible", "value", "of", "MEK", "inhibitors", "for", "RAS-mutant", ",", "as", "well", "as", "RAS-wildtype", ",", "MLL", "rearranged", "infant", "ALL", "patients", "." ],
  "event_indices" : [ 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43 ],
  "type" : "Positive_activation",
  "polarity" : true,
  "controller_indices" : [ 7, 8 ],
  "controlled_indices" : [ 42, 43 ],
  "trigger_indices" : [ 10, 11 ],
  "rule_name" : "Positive_activation_syntax_1_verb",
  "rule" : null
}, {
  "sentence_tokens" : [ "Moreover", ",", "RAS", "pathway", "inhibition", ",", "including", "MEK", "inhibition", ",", "was", "previously", "shown", "to", "effectively", "inhibit", "RAS-mutant", "MLL", "rearranged", "AML", "in", "vitro", "[", "5", ",", "6", "]", "." ],
  "event_indices" : [ 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18 ],
  "type" : "Negative_activation",
  "polarity" : false,
  "controller_indices" : [ 2, 3 ],
  "controlled_indices" : [ 17, 18 ],
  "trigger_indices" : [ 15, 16 ],
  "rule_name" : "Negative_activation_syntax_1_verb",
  "rule" : null
}, {
  "sentence_tokens" : [ "As", "shown", "in", "Figure", "6A", ",", "prednisolone", "alone", "decreased", "cell", "viability", "of", "SEM", "cells", "to", "only", "~", "50", "%", "." ],
  "event_indices" : [ 6, 7, 8, 9, 10, 11 ],
  "type" : "Negative_activation",
  "polarity" : false,
  "controller_indices" : [ 6, 7 ],
  "controlled_indices" : [ 9, 10, 11 ],
  "trigger_indices" : [ 8, 9 ],
  "rule_name" : "Negative_activation_syntax_1_verb",
  "rule" : null
}, {
  "sentence_tokens" : [ "Moreover", ",", "RAS", "pathway", "inhibition", ",", "including", "MEK", "inhibition", ",", "was", "previously", "shown", "to", "effectively", "inhibit", "RAS-mutant", "MLL", "rearranged", "AML", "in", "vitro", "[", "5", ",", "6", "]", "." ],
  "event_indices" : [ 2, 3, 4, 5, 6, 7, 8 ],
  "type" : "Positive_activation",
  "polarity" : true,
  "controller_indices" : [ 7, 8 ],
  "controlled_indices" : [ 2, 3 ],
  "trigger_indices" : [ 4, 5 ],
  "rule_name" : "Negative_activation_syntax_noun_Hearst",
  "rule" : null
}, {
  "sentence_tokens" : [ "Activated", "ERK", "can", "phosphorylate", "BIM", ",", "targeting", "it", "for", "proteasomal", "degradation", ",", "and", "thereby", "diminishing", "apoptosis", "induced", "by", "dexamethasone", "[", "26", "]", "." ],
  "event_indices" : [ 15, 16, 17, 18, 19 ],
  "type" : "Positive_activation",
  "polarity" : true,
  "controller_indices" : [ 18, 19 ],
  "controlled_indices" : [ 15, 16 ],
  "trigger_indices" : [ 16, 17 ],
  "rule_name" : "Positive_activation_syntax_2_verb",
  "rule" : null
}, {
  "sentence_tokens" : [ "Temsirolimus", "and", "Sorafenib", "potently", "reduced", "cell", "viability", "of", "both", "RAS-mutant", "and", "RAS-wildtype", "cell", "lines", "." ],
  "event_indices" : [ 2, 3, 4, 5, 6, 7 ],
  "type" : "Negative_activation",
  "polarity" : false,
  "controller_indices" : [ 2, 3 ],
  "controlled_indices" : [ 5, 6, 7 ],
  "trigger_indices" : [ 4, 5 ],
  "rule_name" : "Negative_activation_syntax_1_verb",
  "rule" : null
}, {
  "sentence_tokens" : [ "Temsirolimus", "and", "Sorafenib", "potently", "reduced", "cell", "viability", "of", "both", "RAS-mutant", "and", "RAS-wildtype", "cell", "lines", "." ],
  "event_indices" : [ 0, 1, 2, 3, 4, 5, 6, 7 ],
  "type" : "Negative_activation",
  "polarity" : false,
  "controller_indices" : [ 0, 1 ],
  "controlled_indices" : [ 5, 6, 7 ],
  "trigger_indices" : [ 4, 5 ],
  "rule_name" : "Negative_activation_syntax_1_verb",
  "rule" : null
}, {
  "sentence_tokens" : [ "Interestingly", ",", "while", "Trametinib", "by", "itself", "induced", "only", "minor", "cell", "viability", "decrease", "in", "SEM", "cells", "(", "Figure", "6B", ")", ",", "the", "combination", "of", "Trametinib", "and", "prednisolone", "greatly", "enhanced", "the", "efficacy", "of", "prednisolone", ",", "especially", "at", "higher", "concentrations", "(", "Figure", "6A", ")", "." ],
  "event_indices" : [ 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28 ],
  "type" : "Negative_activation",
  "polarity" : false,
  "controller_indices" : [ 23, 24 ],
  "controlled_indices" : [ 9, 10, 11 ],
  "trigger_indices" : [ 27, 28 ],
  "rule_name" : "Positive_activation_syntax_1_verb",
  "rule" : null
}, {
  "sentence_tokens" : [ "Moreover", ",", "Ari", "e", "s", "et", "al.", "found", "Trametinib", "could", "restore", "prednisolone", "sensitivity", "in", "RAS-mutant", "BCP-ALL", "patient", "samples", ",", "whereas", "Rambal", "et", "al.", "showed", "that", "MEK", "activation", "reduces", "dexamethasone", "sensitivity", ",", "and", "the", "MEK", "inhibitor", "PD183452", "enhanced", "dexamethasone", "responses", "in", "ALL", "cells", "in", "a", "BIM", "dependent", "manner", "[", "24", ",", "25", "]", "." ],
  "event_indices" : [ 35, 36, 37, 38 ],
  "type" : "Negative_activation",
  "polarity" : false,
  "controller_indices" : [ 35, 36 ],
  "controlled_indices" : [ 37, 38 ],
  "trigger_indices" : [ 36, 37 ],
  "rule_name" : "Positive_activation_syntax_1_verb",
  "rule" : null
}, {
  "sentence_tokens" : [ "Since", "SEM", "cells", "responded", "modestly", "to", "MEK", "inhibition", "but", "did", "show", "a", "significant", "loss", "of", "p-ERK", "levels", ",", "we", "investigated", "whether", "these", "cells", "could", "circumvent", "loss", "of", "ERK", "activation", "by", "upregulating", "RAS", "mediated", "PI3K-Akt-mTOR", "signaling", "." ],
  "event_indices" : [ 31, 32, 33, 34 ],
  "type" : "Positive_activation",
  "polarity" : true,
  "controller_indices" : [ 31, 32 ],
  "controlled_indices" : [ 33, 34 ],
  "trigger_indices" : [ 32, 33 ],
  "rule_name" : "Positive_early_activation",
  "rule" : null
}, {
  "sentence_tokens" : [ "The", "MEK", "inhibitors", "MEK162", ",", "Selumetinib", "and", "Trametinib", "significantly", "reduce", "viability", "of", "RAS-mutant", "MLL", "rearranged", "ALL", "cells", "." ],
  "event_indices" : [ 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14 ],
  "type" : "Positive_activation",
  "polarity" : true,
  "controller_indices" : [ 3, 4 ],
  "controlled_indices" : [ 13, 14 ],
  "trigger_indices" : [ 9, 10 ],
  "rule_name" : "Negative_activation_syntax_1_verb",
  "rule" : null
}, {
  "sentence_tokens" : [ "MEK", "inhibitors", "induce", "apoptosis", "." ],
  "event_indices" : [ 0, 1, 2, 3, 4 ],
  "type" : "Negative_activation",
  "polarity" : false,
  "controller_indices" : [ 0, 1, 2 ],
  "controlled_indices" : [ 3, 4 ],
  "trigger_indices" : [ 2, 3 ],
  "rule_name" : "Positive_activation_syntax_1_verb",
  "rule" : null
}, {
  "sentence_tokens" : [ "However", ",", "we", "did", "confirm", "that", "MEK", "inhibitors", "reduced", "p-ERK", "levels", ",", "and", "induced", "apoptosis", "in", "the", "RAS-mutant", "MLL", "rearranged", "ALL", "cells", "." ],
  "event_indices" : [ 6, 7, 8, 9, 10, 11, 12, 13, 14, 15 ],
  "type" : "Positive_activation",
  "polarity" : true,
  "controller_indices" : [ 6, 7, 8 ],
  "controlled_indices" : [ 14, 15 ],
  "trigger_indices" : [ 13, 14 ],
  "rule_name" : "Positive_activation_syntax_1_verb",
  "rule" : null
}, {
  "sentence_tokens" : [ "However", ",", "we", "did", "confirm", "that", "MEK", "inhibitors", "reduced", "p-ERK", "levels", ",", "and", "induced", "apoptosis", "in", "the", "RAS-mutant", "MLL", "rearranged", "ALL", "cells", "." ],
  "event_indices" : [ 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19 ],
  "type" : "Positive_activation",
  "polarity" : true,
  "controller_indices" : [ 6, 7, 8 ],
  "controlled_indices" : [ 18, 19 ],
  "trigger_indices" : [ 13, 14 ],
  "rule_name" : "Positive_activation_syntax_7_verb",
  "rule" : null
}, {
  "sentence_tokens" : [ "This", "is", "further", "supported", "by", "our", "previous", "study", "showing", "that", "in", "MLL", "rearranged", "ALL", ",", "prednisolone", "sensitization", "mediated", "by", "pan-BCL-2", "family", "inhibitors", "was", "largely", "driven", "by", "the", "up-regulation", "of", "pro", "apoptotic", "BID", "and", "BIM", "[", "27", "]", "." ],
  "event_indices" : [ 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34 ],
  "type" : "Positive_activation",
  "polarity" : true,
  "controller_indices" : [ 33, 34 ],
  "controlled_indices" : [ 16, 17 ],
  "trigger_indices" : [ 24, 25 ],
  "rule_name" : "Positive_activation_syntax_2_verb",
  "rule" : null
}, {
  "sentence_tokens" : [ "This", "is", "further", "supported", "by", "our", "previous", "study", "showing", "that", "in", "MLL", "rearranged", "ALL", ",", "prednisolone", "sensitization", "mediated", "by", "pan-BCL-2", "family", "inhibitors", "was", "largely", "driven", "by", "the", "up-regulation", "of", "pro", "apoptotic", "BID", "and", "BIM", "[", "27", "]", "." ],
  "event_indices" : [ 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34 ],
  "type" : "Positive_activation",
  "polarity" : true,
  "controller_indices" : [ 33, 34 ],
  "controlled_indices" : [ 13, 14 ],
  "trigger_indices" : [ 24, 25 ],
  "rule_name" : "Positive_activation_syntax_2_verb",
  "rule" : null
}, {
  "sentence_tokens" : [ "This", "is", "further", "supported", "by", "our", "previous", "study", "showing", "that", "in", "MLL", "rearranged", "ALL", ",", "prednisolone", "sensitization", "mediated", "by", "pan-BCL-2", "family", "inhibitors", "was", "largely", "driven", "by", "the", "up-regulation", "of", "pro", "apoptotic", "BID", "and", "BIM", "[", "27", "]", "." ],
  "event_indices" : [ 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32 ],
  "type" : "Positive_activation",
  "polarity" : true,
  "controller_indices" : [ 31, 32 ],
  "controlled_indices" : [ 13, 14 ],
  "trigger_indices" : [ 24, 25 ],
  "rule_name" : "Positive_activation_syntax_2_verb",
  "rule" : null
}, {
  "sentence_tokens" : [ "This", "is", "further", "supported", "by", "our", "previous", "study", "showing", "that", "in", "MLL", "rearranged", "ALL", ",", "prednisolone", "sensitization", "mediated", "by", "pan-BCL-2", "family", "inhibitors", "was", "largely", "driven", "by", "the", "up-regulation", "of", "pro", "apoptotic", "BID", "and", "BIM", "[", "27", "]", "." ],
  "event_indices" : [ 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32 ],
  "type" : "Positive_activation",
  "polarity" : true,
  "controller_indices" : [ 31, 32 ],
  "controlled_indices" : [ 16, 17 ],
  "trigger_indices" : [ 24, 25 ],
  "rule_name" : "Positive_activation_syntax_2_verb",
  "rule" : null
}, {
  "sentence_tokens" : [ "MEK", "inhibition", "is", "a", "promising", "therapeutic", "strategy", "for", "MLL", "rearranged", "infant", "acute", "lymphoblastic", "leukemia", "patients", "carrying", "RAS", "mutations", "." ]
}, {
  "sentence_tokens" : [ "Acute", "lymphoblastic", "leukemia", "(", "ALL", ")", "in", "infants", "is", "an", "aggressive", "malignancy", "with", "a", "poor", "clinical", "outcome", ",", "and", "is", "characterized", "by", "translocations", "of", "the", "Mixed", "Lineage", "Leukemia", "(", "MLL", ")", "gene", "." ]
}, {
  "sentence_tokens" : [ "Previously", ",", "we", "identified", "RAS", "mutations", "in", "14-24", "%", "of", "infant", "ALL", "patients", ",", "and", "showed", "that", "the", "presence", "of", "a", "RAS", "mutation", "decreased", "the", "survival", "chances", "even", "further", "." ]
}, {
  "sentence_tokens" : [ "We", "hypothesized", "that", "targeting", "the", "RAS", "signaling", "pathway", "could", "be", "a", "therapeutic", "strategy", "for", "RAS-mutant", "infant", "ALL", "patients", "." ]
}, {
  "sentence_tokens" : [ "While", "all", "RAS-mutant", "samples", "were", "sensitive", "to", "MEK", "inhibitors", ",", "we", "found", "both", "sensitive", "and", "resistant", "samples", "among", "RAS-wildtype", "cases", "." ]
}, {
  "sentence_tokens" : [ "We", "confirmed", "enhanced", "RAS", "pathway", "signaling", "in", "RAS-mutant", "samples", ",", "but", "found", "no", "apparent", "downstream", "over-activation", "in", "the", "wildtype", "samples", "." ]
}, {
  "sentence_tokens" : [ "Finally", ",", "we", "show", "that", "MEK", "inhibition", "synergistically", "enhances", "prednisolone", "sensitivity", ",", "both", "in", "RAS-mutant", "and", "RAS-wildtype", "cells", "." ]
}, {
  "sentence_tokens" : [ "In", "conclusion", ",", "MEK", "inhibition", "represents", "a", "promising", "therapeutic", "strategy", "for", "MLL", "rearranged", "ALL", "patients", "harboring", "RAS", "mutations", ",", "while", "patients", "without", "RAS", "mutations", "may", "benefit", "through", "prednisolone", "sensitization", "." ]
}, {
  "sentence_tokens" : [ "INTRODUCTION", "." ]
}, {
  "sentence_tokens" : [ "Acute", "lymphoblastic", "leukemia", "(", "ALL", ")", "in", "infants", "(", "<", "1", "year", "of", "age", ")", "represents", "an", "aggressive", "malignancy", ",", "associated", "with", "high", "relapse", "rates", "and", "a", "poor", "clinical", "outcome", "[", "1", "]", "." ]
}, {
  "sentence_tokens" : [ "The", "majority", "(", "~", "80", "%", ")", "of", "these", "patients", "carry", "a", "leukemia", "specific", "chromosomal", "translocations", "involving", "the", "Mixed", "Lineage", "Leukemia", "(", "MLL", ")", "gene", "[", "1", "]", "." ]
}, {
  "sentence_tokens" : [ "MLL", "rearranged", "infant", "ALL", "patients", "fare", "significantly", "worse", "than", "infant", "ALL", "patients", "who", "do", "not", "carry", "MLL", "translocations", ",", "with", "event-free", "survival", "rates", "of", "30-40", "%", "vs.", "~", "80", "%", ",", "respectively", "[", "2", "]", "." ]
}, {
  "sentence_tokens" : [ "Recently", ",", "we", "demonstrated", "that", "24", "%", "of", "the", "infant", "ALL", "patients", "carrying", "MLL", "translocation", "t", "(", "4", ";", "11", ")", ",", "the", "most", "frequently", "observed", "translocation", "of", "MLL", "among", "these", "patients", ",", "also", "carry", "a", "RAS", "mutation", "." ]
}, {
  "sentence_tokens" : [ "Mutations", "in", "NRAS", "were", "found", "in", "11", "%", "and", "KRAS", "mutations", "in", "13", "%", "of", "cases", "[", "3", "]", "." ]
}, {
  "sentence_tokens" : [ "Moreover", ",", "we", "showed", "that", "the", "presence", "of", "a", "RAS", "mutation", "in", "MLL", "rearranged", "patients", "represented", "an", "independent", "predictive", "factor", "for", "an", "even", "worse", "clinical", "outcome", "in", "this", "high-risk", "group", "." ]
}, {
  "sentence_tokens" : [ "Nearly", "all", "RAS-mutant", "t", "(", "4", ";", "11", ")", "infant", "ALL", "patients", "relapsed", "within", "the", "first", "year", "from", "diagnosis", ",", "while", "still", "on", "treatment", ",", "and", "all", "died", "within", "4", "years", "from", "diagnosis", "[", "3", "]", "." ]
}, {
  "sentence_tokens" : [ "Despite", "this", "strong", "association", "with", "an", "exceedingly", "poor", "prognosis", ",", "a", "recent", "study", "by", "Emerenciano", "et", "al.", "suggested", "that", "RAS", "mutations", "in", "MLL", "rearranged", "infant", "ALL", "may", "not", "act", "as", "driver", "mutations", "and", "are", "not", "required", "for", "disease", "progression", ",", "but", "rather", "act", "only", "at", "disease", "onset", "[", "4", "]", "." ]
}, {
  "sentence_tokens" : [ "Yet", ",", "our", "previous", "data", "clearly", "showed", "that", "RAS-mutant", "MLL", "rearranged", "infant", "ALL", "patients", "are", "at", "extremely", "high", "risk", "of", "therapy", "failure", "and", "early", "death", "." ]
}, {
  "sentence_tokens" : [ "Therefore", ",", "we", "decided", "to", "investigate", "the", "potential", "of", "RAS", "pathway", "inhibition", "and", "found", "that", "RAS-mutant", "MLL", "rearranged", "ALL", "cells", "are", "remarkably", "sensitive", "to", "MEK", "inhibitors", "." ]
}, {
  "sentence_tokens" : [ "RESULTS", "." ]
}, {
  "sentence_tokens" : [ "RAS-mutant", "MLL", "rearranged", "ALL", "cells", "are", "sensitive", "to", "MEK", "inhibition", "." ]
}, {
  "sentence_tokens" : [ "Since", "the", "previously", "identified", "RAS", "aberrations", "are", "all", "activating", "mutations", "(", "at", "residues", "G12", ",", "G13", "or", "Q61", ")", ",", "we", "wondered", "whether", "small", "molecule", "inhibitors", "targeting", "RAS", "pathway", "components", "could", "suppress", "RAS-mutant", "leukemic", "cells", "[", "3", ",", "7", "]", "." ]
}, {
  "sentence_tokens" : [ "Therefore", ",", "7", "RAS", "pathway", "inhibitors", ",", "already", "approved", "for", "therapeutical", "use", "or", "under", "clinical", "investigation", "for", "other", "malignancies", "with", "RAS", "pathway", "mutations", ",", "were", "selected", "as", "therapeutic", "strategies", "for", "the", "RAS-mutant", "infant", "ALL", "patients", "." ]
}, {
  "sentence_tokens" : [ "Using", "4-day", "MTS", "cell", "viability", "assays", "we", "tested", "the", "in", "vitro", "anti-leukemic", "potential", "of", "Salirasib", "(", "RAS", "localization", "inhibitor", ")", ",", "Vemurafenib", "(", "BRAF", "inhibitor", ")", ",", "Sorafenib", "(", "pan-kinase", "inhibitor", ")", ",", "Trametinib", ",", "Selumetinib", "and", "MEK162", "(", "MEK", "inhibitors", ")", "and", "Temsirolimus", "(", "mTOR", "inhibitor", ")", "against", "RAS-mutant", "MLL", "rearranged", "ALL", "cell", "line", "KOPN8", ",", "and", "the", "RAS-wildtype", "MLL", "rearranged", "cell", "lines", "SEM", "and", "RS4", ";", "11", "." ]
}, {
  "sentence_tokens" : [ "Interestingly", ",", "the", "RAS-mutant", "cell", "line", "KOPN8", "was", "more", "sensitive", "to", "the", "MEK", "inhibitors", "MEK162", ",", "Selumetinib", "and", "Trametinib", "(", "Figure", "1", ")", "." ]
}, {
  "sentence_tokens" : [ "To", "confirm", "the", "efficacy", "of", "these", "inhibitors", ",", "we", "performed", "4-day", "MTT", "cell", "viability", "assays", "on", "primary", "diagnostic", "RAS-mutant", "(", "n", "=", "6", ")", "and", "RAS-wildtype", "(", "n", "=", "14", ")", "t", "(", "4", ";", "11", ")", "infant", "ALL", "samples", "." ]
}, {
  "sentence_tokens" : [ "Interestingly", ",", "compared", "to", "RAS-wildtype", "t", "(", "4", ";", "11", ")", "ALL", "cases", ",", "the", "RAS-mutant", "t", "(", "4", ";", "11", ")", "infant", "ALL", "cases", "were", "significantly", "more", "sensitive", "to", "all", "MEK", "inhibitors", "(", "Figure", "2A", ")", "with", "median", "IC", "values", "of", "<", "0.1", "mu", "M", "for", "MEK162", "and", "Selumetinib", "and", "<", "0.01", "mu", "M", "for", "Trametinib", "(", "Figure", "2B", ")", "." ]
}, {
  "sentence_tokens" : [ "Additionally", ",", "all", "other", "tested", "inhibitors", "(", "Salirasib", ",", "Temsirolimus", ",", "Sorafenib", "and", "Vemurafenib", ")", "reached", "only", "IC", "values", "of", ">", "10", "mu", "M", "(", "Supplementary", "Figure", "1", ")", "." ]
}, {
  "sentence_tokens" : [ "Also", ",", "we", "included", "one", "matched", "pair", "of", "diagnostic", "and", "relapse", "t", "(", "4", ";", "11", ")", "samples", "." ]
}, {
  "sentence_tokens" : [ "For", "this", "particular", "patient", ",", "no", "RAS", "mutation", "was", "present", "at", "diagnosis", ",", "but", "a", "RAS", "mutation", "could", "be", "identified", "at", "relapse", "." ]
}, {
  "sentence_tokens" : [ "Indeed", ",", "the", "RAS-mutant", "relapse", "sample", "of", "this", "patient", "was", "more", "sensitive", "to", "all", "three", "MEK", "inhibitors", "tested", "than", "the", "RAS-wildtype", "diagnostic", "sample", "(", "Figure", "2B", ")", "." ]
}, {
  "sentence_tokens" : [ "Enhanced", "RAS", "activation", "in", "t", "(", "4", ";", "11", ")", "+", "infant", "ALL", "cells", "carrying", "RAS", "mutations", "." ]
}, {
  "sentence_tokens" : [ "Notably", ",", "a", "subset", "of", "the", "RAS-wildtype", "primary", "t", "(", "4", ";", "11", ")", "infant", "ALL", "samples", "also", "responded", "favorably", "to", "the", "MEK", "inhibitors", "(", "Figure", "2B", ")", "." ]
}, {
  "sentence_tokens" : [ "We", "wondered", "whether", "other", "biomarkers", ",", "besides", "RAS", "mutation", "status", ",", "could", "predict", "MEK", "inhibitor", "sensitivity", "in", "MLL", "rearranged", "ALL", "." ]
}, {
  "sentence_tokens" : [ "Wildtype", "RAS", "proteins", "are", "under", "regulation", "of", "upstream", "signaling", "events", ",", "often", "involving", "tyrosine", "kinase", "receptors", ",", "while", "mutant", "RAS", "proteins", "are", "less", "dependent", "on", "upstream", "activation", "due", "to", "reduced", "GTPase", "activity", ",", "rendering", "a", "surplus", "of", "activated", "GTP", "bound", "RAS", "." ]
}, {
  "sentence_tokens" : [ "Therefore", ",", "we", "determined", "the", "RAS", "protein", "levels", "and", "RAS", "activity", "in", "our", "primary", "t", "(", "4", ";", "11", ")", "infant", "ALL", "cells", "." ]
}, {
  "sentence_tokens" : [ "No", "significant", "difference", "in", "RAS", "protein", "levels", "was", "observed", "between", "the", "RAS-mutant", "and", "RAS-wildtype", "t", "(", "4", ";", "11", ")", "infant", "ALL", "samples", "using", "Western", "blot", "analysis", "(", "Figure", "3A", ")", "." ]
}, {
  "sentence_tokens" : [ "Next", ",", "we", "investigated", "the", "level", "of", "active", "(", "GTP", "bound", ")", "RAS", "in", "these", "samples", "by", "precipitation", "with", "RAF-1", "RAS", "interaction", "peptide", ",", "followed", "by", "immunoblotting", "." ]
}, {
  "sentence_tokens" : [ "As", "expected", ",", "the", "RAS-mutant", "t", "(", "4", ";", "11", ")", "infant", "ALL", "samples", "showed", "significant", "(", "p", "=0", ".013", ")", "higher", "levels", "of", "RAS", "activation", "as", "compared", "to", "RAS-wildtype", "samples", "(", "Figure", "3B", ")", "." ]
}, {
  "sentence_tokens" : [ "No", "differences", "in", "RAS", "activation", "were", "observed", "between", "RAS-wildtype", "samples", "that", "were", "sensitive", "or", "resistant", "to", "MEK", "inhibition.Subsequently", ",", "we", "determined", "phosphorylation", "levels", "of", "MEK", "(", "p-MEK", ")", "and", "ERK", "(", "p-ERK", ")", "by", "immunoblotting", "(", "Supplementary", "Figure", "2A", "and", "2B", ",", "respectively", ")", "." ]
}, {
  "sentence_tokens" : [ "Quantification", "of", "the", "blots", "indicated", "a", "significantly", "higher", "level", "of", "p-MEK", "in", "our", "RAS-mutant", "samples", ",", "compared", "to", "RAS-wildtype", "samples", "(", "p", "=0", ".0312", ",", "Figure", "3C", ")", ",", "although", "there", "was", "no", "difference", "in", "p-MEK", "levels", "between", "the", "MEK", "inhibitor", "resistant", "and", "sensitive", "RAS-wildtype", "subgroups", "." ]
}, {
  "sentence_tokens" : [ "Still", ",", "we", "did", "find", "a", "higher", "p-MEK", "level", "in", "the", "mutated", "relapse", "sample", "compared", "to", "its", "matched", "wildtype", "diagnosis", "sample", "." ]
}, {
  "sentence_tokens" : [ "Furthermore", ",", "we", "previously", "found", "MLL", "rearranged", "ALL", "is", "characterized", "by", "high", "expression", "of", "Fms", "like", "tyrosine", "kinase", "3", "(", "FLT3", ")", "[", "8]", "." ]
}, {
  "sentence_tokens" : [ "Therefore", ",", "we", "interrogated", "available", "gene", "expression", "profiles", "of", "primary", "samples", "for", "possible", "differences", "in", "TKR", "expression", "levels", "between", "the", "MEK", "inhibitor", "sensitive", "and", "resistant", "subgroups", "(", "Supplementary", "Figure", "3", ")", "." ]
}, {
  "sentence_tokens" : [ "Interestingly", ",", "apart", "from", "FLT3", ",", "expression", "of", "TKRs", "is", "relatively", "low", "in", "the", "different", "patient", "samples", "." ]
}, {
  "sentence_tokens" : [ "Surprisingly", ",", "FGFR-1", "expression", "is", "significantly", "lower", "in", "MEK", "inhibitor", "resistant", "RAS-wildtype", "samples", "(", "p", "=0", ".02", ")", ",", "while", "there", "are", "no", "significant", "differences", "in", "expression", "of", "FLT3", ",", "VEGFR", "(", "1-3", ")", ",", "FGFR", "(", "2-4", ")", ",", "EGFR", "and", "ERBB", "(", "2-4", ")", ",", "PDGFR", "(", "A-B", ")", "or", "Lck", "and", "Src", "." ]
}, {
  "sentence_tokens" : [ "MEK", "inhibition", "results", "in", "reduced", "ERK", "phosphorylation", "." ]
}, {
  "sentence_tokens" : [ "Next", ",", "we", "exposed", "MLL", "rearranged", "ALL", "cell", "lines", "SEM", "and", "KOPN8", "to", "the", "MEK", "inhibitors", "(", "Selumetinib", ",", "MEK162", "and", "Trametinib", ")", "and", "determined", "p-ERK", "and", "p-MEK", "levels", "by", "immunoblotting", "(", "Figure", "4", ")", "." ]
}, {
  "sentence_tokens" : [ "Interestingly", ",", "p-ERK", "levels", "were", "drastically", "reduced", "in", "both", "SEM", "and", "KOPN8", ",", "already", "after", "6", "hours", "of", "exposure", ",", "and", "this", "effect", "was", "sustained", "for", "at", "least", "48", "hours", ",", "regardless", "of", "the", "inhibitor", "used", "(", "Figure", "4A", ")", "." ]
}, {
  "sentence_tokens" : [ "Furthermore", ",", "prolonged", "exposure", "(", "24", "and", "48", "hours", ")", "to", "the", "MEK", "inhibitors", "Selumetinib", "and", "MEK162", "resulted", "in", "an", "increase", "of", "p-MEK", "in", "SEM", "and", "KOPN8", "(", "Figure", "4B", ")", "." ]
}, {
  "sentence_tokens" : [ "Additionally", ",", "we", "determined", "phosphorylation", "of", "ERKs", "downstream", "effector", "ELK-1", ",", "but", "ELK-1", "activation", "was", "not", "influenced", "by", "MEK", "inhibition", "(", "Supplementary", "Figure", "4A", ")", "." ]
}, {
  "sentence_tokens" : [ "Therefore", ",", "the", "downstream", "phosphorylation", "of", "Akt", "(", "Ser437", ")", "and", "p70S6K", "(", "Thr389", ")", "was", "assessed", "by", "immunoblotting", "." ]
}, {
  "sentence_tokens" : [ "However", ",", "no", "differences", "in", "Akt", "and", "p70S6K", "phosphorylation", "were", "observed", "in", "response", "to", "MEK", "inhibitor", "exposure", "(", "Supplementary", "Figure", "4B", "and", "4C", ")", "." ]
}, {
  "sentence_tokens" : [ "Subsequently", ",", "we", "investigated", "the", "phenotypic", "effects", "of", "the", "MEK", "inhibitors", "on", "SEM", "and", "KOPN8", "through", "analysis", "of", "early", "and", "late", "apoptosis", "markers", "(", "Annexin-V", "and", "7-AAD", ",", "respectively", ")", ",", "using", "flow-cytometry", "." ]
}, {
  "sentence_tokens" : [ "Interestingly", ",", "both", "RAS-wildtype", "SEM", "and", "RAS-mutant", "KOPN8", "undergo", "early", "apoptosis", ",", "after", "treatment", "with", "MEK", "inhibitor", "(", "Figure", "5A", "and", "5B", ",", "respectively", ")", "." ]
}, {
  "sentence_tokens" : [ "However", ",", "while", "late", "apoptosis", "is", "barely", "observed", "for", "SEM", "(", "Figure", "5C", ")", ",", "late", "apoptosis", "in", "MEK", "inhibitor", "exposed", "KOPN8", "cells", "is", "enhanced", "substantially", ",", "especially", "after", "prolonged", "exposure", "(", "Figure", "5D", ")", ",", "suggesting", "the", "response", "to", "MEK", "inhibition", "is", "characterized", "by", "increased", "apoptosis", "." ]
}, {
  "sentence_tokens" : [ "Additionally", ",", "we", "investigated", "cell", "cycle", "progression", "under", "influence", "of", "MEK", "inhibition", "." ]
}, {
  "sentence_tokens" : [ "Interestingly", ",", "no", "considerable", "differences", "in", "SEM", "or", "KOPN8", "cell", "cycle", "progression", "were", "observed", "after", "96", "hours", "exposure", "to", "MEK162", ",", "Selumetinib", "or", "Trametinib", "(", "Figure", "5E", "and", "5F", ",", "respectively", ")", ",", "nor", "after", "exposure", "for", "24", ",", "48", "and", "72", "hours", "(", "Supplementary", "Figure", "6A-6B", ",", "6C-6D", "and", "6E-6F", ",", "respectively", ")", "." ]
}, {
  "sentence_tokens" : [ "MEK", "inhibition", "enhances", "prednisolone", "sensitivity", "." ]
}, {
  "sentence_tokens" : [ "In", "our", "previous", "study", ",", "we", "found", "that", "MLL", "rearranged", "infant", "ALL", "patient", "samples", "harboring", "RAS", "mutations", "are", "more", "resistant", "to", "prednisolone", "[", "3", "]", "." ]
}, {
  "sentence_tokens" : [ "Therefore", ",", "we", "examined", "whether", "inhibition", "of", "MEK", "could", "enhance", "prednisolone", "sensitivity", "of", "RAS-mutant", "cells", "." ]
}, {
  "sentence_tokens" : [ "The", "combination", "of", "prednisolone", "and", "Trametinib", "also", "strongly", "decreased", "cell", "viability", "in", "KOPN8", "more", "potently", "than", "either", "drug", "alone", ";", "low", "concentrations", "of", "Trametinib", "nearly", "eradicated", "all", "KOPN8", "cells", "that", "did", "not", "respond", "to", "prednisolone", "treatment", "(", "Figure", "6C", ")", "." ]
}, {
  "sentence_tokens" : [ "A", "similar", "sensitizing", "effect", "was", "observed", "when", "exposing", "SEM", "and", "KOPN8", "to", "MEK162", "or", "Selumetinib", "in", "combination", "with", "prednisolone", "(", "Supplementary", "Figure", "7A-7D", "and", "7F-7I", ",", "respectively", ")", "." ]
}, {
  "sentence_tokens" : [ "Since", "Trametinib", "alone", "already", "effectively", "decreases", "viability", "of", "KOPN8", "cells", "(", "Figure", "6D", ")", ",", "we", "quantified", "the", "combinatorial", "effect", "of", "MEK", "inhibitors", "and", "prednisolone", "using", "the", "synergy", "factor", "(", "F", ")", "calculation", ",", "as", "previously", "described", "[", "9", ",", "10", "]", "." ]
}, {
  "sentence_tokens" : [ "The", "plot", "in", "Figure", "6E", "shows", "the", "fractional", "effect", "(", "i.e.", "the", "relative", "decrease", "of", "cell", "viability", ")", "induced", "by", "the", "combination", "of", "Trametinib", "with", "prednisolone", ",", "and", "the", "corresponding", "Synergy", "Factor", "." ]
}, {
  "sentence_tokens" : [ "Interestingly", ",", "in", "both", "SEM", "and", "KOPN8", "cells", "we", "observed", "F", "values", "<", "0.5", ",", "indicating", "strong", "synergy", "between", "Trametinib", "and", "prednisolone", "." ]
}, {
  "sentence_tokens" : [ "Also", "combining", "MEK162", "or", "Selumetinib", "with", "prednisolone", "resulted", "in", "moderate", "to", "strong", "synergistic", "effects", "(", "Supplementary", "Figure", "7E", "and", "7J", ",", "respectively", ")", "." ]
}, {
  "sentence_tokens" : [ "Additionally", ",", "we", "investigated", "whether", "this", "enhanced", "effect", "was", "related", "to", "differential", "expression", "of", "the", "glucocorticoid", "receptor", "(", "GR", ")", ",", "the", "target", "of", "prednisolone", "." ]
}, {
  "sentence_tokens" : [ "However", ",", "MEK", "inhibitor", "exposure", "did", "not", "alter", "GR", "protein", "levels", "in", "either", "SEM", "or", "KOPN8", "cells", "(", "Supplementary", "Figure", "7K", ")", "." ]
}, {
  "sentence_tokens" : [ "DISCUSSION", "." ]
}, {
  "sentence_tokens" : [ "MLL", "rearranged", "ALL", "in", "infants", "is", "a", "high-risk", "hematologic", "malignancy", ",", "characterized", "by", "a", "high", "incidence", "of", "relapse", "and", "high", "mortality", "rate", "[", "11", "]", "." ]
}, {
  "sentence_tokens" : [ "Recently", ",", "we", "showed", "that", "14-24", "%", "of", "these", "patients", "carry", "a", "RAS", "mutation", ",", "as", "an", "independent", "predictor", "of", "extremely", "poor", "outcome", "[", "3", "]", "." ]
}, {
  "sentence_tokens" : [ "In", "the", "present", "study", ",", "we", "demonstrate", "that", "the", "MEK", "inhibitors", "Trametinib", ",", "Selumetinib", "and", "MEK162", "display", "strong", "anti-leukemic", "effects", "against", "RAS-mutant", "MLL", "rearranged", "ALL", "cells", "." ]
}, {
  "sentence_tokens" : [ "Considering", "the", "dismal", "prognosis", "for", "infants", "suffering", "from", "MLL", "rearranged", "ALL", "with", "additional", "RAS", "mutations", ",", "our", "data", "supports", "application", "of", "these", "inhibitors", "in", "the", "treatment", "of", "this", "patient", "group", "." ]
}, {
  "sentence_tokens" : [ "Moreover", ",", "Trametinib", "has", "recently", "been", "approved", "for", "the", "treatment", "of", "adult", "BRAF", "mutated", "melanoma", ",", "while", "different", "clinical", "trials", "with", "Selumetinib", "and", "MEK162", "show", "promising", "results", "in", "adult", "patients", "with", "RAS", "and", "RAF", "mutation", "positive", "melanoma", "and", "non-small-cell", "lung", "cancer", "[", "14", "-", "18", "]", "." ]
}, {
  "sentence_tokens" : [ "Even", "though", "most", "clinical", "trials", "focused", "on", "solid", "tumors", "in", "adult", "patients", ",", "pediatric", "clinical", "trials", "are", "underway", "for", "neurofibromas", "and", "gliomas", ",", "and", "could", "expedite", "clinical", "application", "of", "these", "MEK", "inhibitors", "in", "MLL", "rearranged", "infant", "ALL.Interestingly", ",", "while", "all", "RAS-mutant", "MLL", "rearranged", "ALL", "patient", "samples", "are", "susceptible", "to", "MEK", "inhibition", ",", "patients", "without", "RAS", "mutations", "also", "might", "benefit", "from", "MEK", "inhibitor", "treatment", ",", "since", "a", "subgroup", "of", "RAS-wildtype", "patient", "samples", "appears", "sensitive", "to", "MEK", "inhibition", "." ]
}, {
  "sentence_tokens" : [ "While", "in", "our", "previous", "study", ",", "we", "identified", "RAS", "mutations", "and", "found", "no", "BRAF", "aberrations", ",", "mutations", "of", "other", "upstream", "regulators", ",", "i.e.", "tyrosine", "kinase", "receptors", ",", "can", "occur", "in", "other", "malignancies", "[", "3", "]", "." ]
}, {
  "sentence_tokens" : [ "Andersson", "et", "al.", "recently", "showed", "that", "additional", "somatic", "mutations", "in", "MLL", "rearranged", "infant", "ALL", ",", "like", "(", "sub-)", "clonal", "RAS", "and", "PI3K", "pathway", "aberrations", ",", "occur", "in", "up", "to", "50", "%", "of", "the", "cases", ",", "supporting", "our", "previous", "observation", "that", "RAS", "mutations", "in", "MLL", "rearranged", "infant", "ALL", "frequently", "occur", "at", "a", "sub-clonal", "level", "[", "3", ",", "19", "]", "." ]
}, {
  "sentence_tokens" : [ "These", "findings", "do", "not", "support", "the", "hypothesis", "that", "other", "(", "upstream", ")", "mutations", "are", "driving", "RAS-MEK-ERK", "signaling", ",", "but", "also", "do", "not", "explain", "observed", "extensive", "MEK", "inhibitor", "sensitivity", "of", "all", "(", "subclonal", ")", "RAS-mutant", "and", "specified", "RAS-wildtype", "patient", "samples", "." ]
}, {
  "sentence_tokens" : [ "While", "we", "found", "enhanced", "RAS", "and", "MEK", "activation", "in", "RAS-mutant", "samples", ",", "these", "biomarkers", "could", "not", "differentiate", "MEK", "inhibitor", "sensitive", "and", "resistant", "RAS-wildtype", "samples", "." ]
}, {
  "sentence_tokens" : [ "However", ",", "we", "observed", "no", "difference", "in", "downstream", "PI3K", "signalling", "(", "i.e.", "Akt", "or", "p70S6K", "phosphorylation", ")", "in", "response", "to", "MEK", "inhibitor", "exposure", "." ]
}, {
  "sentence_tokens" : [ "Additionally", ",", "we", "discovered", "no", "significant", "tyrosine", "kinase", "receptor", "expression", "differences", "in", "MLL", "rearranged", "infant", "ALL", "patient", "samples", "that", "could", "explain", "the", "MEK", "inhibitor", "response", "of", "RAS-wildtype", "samples", "." ]
}, {
  "sentence_tokens" : [ "Surprisingly", ",", "FGFR-1", "expression", "was", "lower", "in", "MEK", "inhibitor", "resistant", "samples", ",", "but", "it", "is", "unclear", "how", "this", "would", "explain", "MEK", "inhibitor", "resistance", "." ]
}, {
  "sentence_tokens" : [ "Alternatively", ",", "Minjgee", "et", "al.", "report", "that", "RAS-mutant", "transfected", "cells", "can", "induce", "downstream", "RAS", "signaling", "in", "a", "paracrine", "manner", ",", "through", "excretion", "of", "cytokines", "[", "20", "]", "." ]
}, {
  "sentence_tokens" : [ "Still", ",", "their", "data", "shows", "that", "leukemic", "cells", "carrying", "the", "t", "(", "4", ";", "11", ")", "translocation", "are", "sensitive", "to", "small", "molecule", "inhibitors", "of", "ERK", "phosphorylation", "." ]
}, {
  "sentence_tokens" : [ "These", "findings", "indicate", "alternative", "regulatory", "mechanisms", "for", "ERK", "signaling", "in", "MLL", "rearranged", "leukemia", "could", "explain", "the", "MEK", "inhibitor", "sensitivity", "we", "observe", "in", "RAS-wildtype", "cells.Loss", "of", "ERK", "phosphorylation", "in", "response", "to", "MEK162", ",", "Selumetinib", "or", "Trametinib", "exposure", "confirmed", "the", "effect", "of", "MEK", "inhibition", "." ]
}, {
  "sentence_tokens" : [ "Interestingly", ",", "prolonged", "exposure", "of", "cells", "to", "MEK162", "or", "Selumetinib", "resulted", "in", "increased", "MEK", "phosphorylation", "." ]
}, {
  "sentence_tokens" : [ "Previously", ",", "Hatzivassiliou", "et", "al.", "showed", "that", "the", "aromatic", "fluorine", "of", "allosteric", "MEK", "inhibitor", "GDC-0973", "interacts", "with", "MEK", "residue", "S212", "[", "22", "]", "." ]
}, {
  "sentence_tokens" : [ "Their", "data", "indicate", "this", "interaction", "results", "in", "exposure", "of", "the", "phosphorylation", "sites", "S218", "and", "S222", ",", "which", "are", "then", "susceptible", "to", "RAF", "mediated", "phosphorylation", "." ]
}, {
  "sentence_tokens" : [ "Since", "MEK162", "and", "Selumetinib", "both", "have", "this", "aromatic", "fluorine", ",", "the", "mechanism", "of", "interaction", "with", "MEK", "is", "probably", "similar", "to", "GDC-0973", "." ]
}, {
  "sentence_tokens" : [ "The", "prednisolone", "sensitizing", "effect", "of", "MEK", "inhibitors", "proposes", "a", "possible", "role", "for", "RAS-MEK-ERK", "signaling", "in", "the", "response", "to", "glucocorticoids", "." ]
}, {
  "sentence_tokens" : [ "Recent", "work", "by", "Jones", "et", "al.", "shows", "that", "MEK", "plays", "a", "key", "role", "in", "drug", "resistance", "in", "relapsed", "pediatric", "ALL", ",", "and", "that", "MEK", "inhibition", "can", "sensitize", "ALL", "relapse", "samples", "to", "chemotherapeutics", ",", "including", "methylprednisolone", "[", "23", "]", "." ]
}, {
  "sentence_tokens" : [ "Moreover", ",", "we", "established", "that", ",", "while", "glucocorticoid", "receptor", "expression", "remains", "constant", ",", "MEK", "inhibition", "upregulates", "pro", "apoptotic", "BIM", ",", "which", "implies", "that", "inhibiting", "MEK", ",", "resulting", "in", "abrogation", "of", "ERK", "phosphorylation", ",", "may", "result", "in", "prolonged", "maintenance", "of", "pro", "apoptotic", "BIM", "activity", "upon", "prednisolone", "exposure", ",", "leading", "to", "enhanced", "prednisolone", "sensitivity", "." ]
}, {
  "sentence_tokens" : [ "In", "summary", ",", "our", "data", "shows", "that", "RAS-mutant", "MLL", "rearranged", "infant", "ALL", "patients", "may", "benefit", "from", "therapeutic", "strategies", "administering", "small-molecule", "MEK", "inhibitors", "." ]
}, {
  "sentence_tokens" : [ "Furthermore", ",", "since", "MEK", "inhibition", "sensitizes", "MLL", "rearranged", "ALL", "cells", "to", "prednisolone", "regardless", "of", "the", "RAS", "mutations", "status", ",", "RAS-wildtype", "MLL", "rearranged", "infant", "ALL", "patients", "may", "also", "benefit", "from", "MEK", "inhibitor", "treatment", "through", "enhanced", "sensitivity", "to", "prednisolone", "." ]
}, {
  "sentence_tokens" : [ "MATERIALS", "AND", "METHODS", "." ]
}, {
  "sentence_tokens" : [ "Patient", "samples", "and", "cell", "lines", "." ]
}, {
  "sentence_tokens" : [ "Bone", "marrow", "and", "peripheral", "blood", "samples", "from", "untreated", "infant", "ALL", "patients", "were", "collected", "at", "the", "Sophia", "Children", "'s", "Hospital", "(", "Rotterdam", ",", "The", "Netherlands", ")", "as", "part", "of", "the", "international", "collaborative", "INTERFANT", "treatment", "protocol", "[", "2", "]", "." ]
}, {
  "sentence_tokens" : [ "Approval", "for", "these", "studies", "was", "obtained", "from", "the", "Erasmus", "MC", "Institutional", "Review", "Board", "." ]
}, {
  "sentence_tokens" : [ "Informed", "consent", "was", "obtained", "according", "to", "the", "Declaration", "of", "Helsinki", "." ]
}, {
  "sentence_tokens" : [ "All", "samples", "were", "processed", "within", "24", "hours", "after", "sampling", "as", "described", "before", ",", "with", "optional", "removal", "of", "contaminating", "non", "leukemic", "cells", "by", "immunomagnetic", "beads", ",", "to", "ensure", "leukemic", "blast", "content", "for", "all", "samples", "was", ">", "90", "%", "[", "8]", "." ]
}, {
  "sentence_tokens" : [ "The", "t", "(", "4", ";", "11", ")-rearranged", "ALL", "cell", "line", "SEM", "and", "t", "(", "11", ";", "19", ")-rearranged", "ALL", "cell", "line", "KOPN8", "were", "purchased", "from", "the", "German", "Collection", "of", "Microorganisms", "and", "Cell", "Cultures", "(", "DSMZ", ",", "Braunschweig", ",", "Germany", ")", ",", "while", "the", "t", "(", "4", ";", "11", ")-rearranged", "ALL", "cell", "line", "RS4", ";", "11", "was", "purchased", "from", "The", "Global", "Biosource", "Center", "(", "ATCC", ",", "Middlesex", ",", "UK", ")", "." ]
}, {
  "sentence_tokens" : [ "All", "cell", "lines", "were", "cultured", "in", "suspension", "in", "RPMI-1640", "with", "GlutaMAX", "(", "Invitrogen", "Life", "Technologies", ",", "Waltham", ",", "MA", ",", "USA", ")", "supplemented", "with", "10", "%", "Fetal", "Calf", "Serum", ",", "100", "IU/mL", "penicillin", ",", "100", "IU/mL", "streptomycin", "and", "0.125", "mu", "g/mL", "amphotericin", "B", "(", "Invitrogen", "Life", "Technologies", ")", "at", "37", "degrees", "C", "under", "5", "%", "CO", "atmosphere", "." ]
}, {
  "sentence_tokens" : [ "In", "vitro", "cytotoxicity", "assay", "and", "small", "molecule", "inhibitors", "." ]
}, {
  "sentence_tokens" : [ "The", "in", "vitro", "cytotoxicity", "of", "MEK162", ",", "Selumetinib", "and", "Trametinib", "(", "MedChem", "Express", ",", "Stockholm", ",", "Sweden", ")", "was", "tested", "by", "MTS", "and", "MTT", "assays", "." ]
}, {
  "sentence_tokens" : [ "All", "inhibitors", "were", "weighed", ",", "dissolved", "in", "dimethyl", "sulfoxide", "(", "DMSO", ")", "and", "stored", "at", "-20", "degrees", "C", "until", "use", "." ]
}, {
  "sentence_tokens" : [ "Cytotoxicity", "assay", "dilutions", "were", "prepared", "in", "cell", "culture", "medium", ",", "keeping", "final", "DMSO", "concentration", "<", "0.5", "%", "." ]
}, {
  "sentence_tokens" : [ "Final", "concentrations", "of", "the", "small", "molecule", "inhibitors", "ranged", "from", "50", "mu", "M", "to", "0.15", "nM", ",", "indicated", "in", "the", "respective", "figures", "." ]
}, {
  "sentence_tokens" : [ "The", "in", "vitro", "sensitivity", "of", "cell", "lines", "was", "assessed", "by", "using", "4-day", "MTS", "conversion", "assays", ",", "as", "described", "previously", "[", "28", "]", "." ]
}, {
  "sentence_tokens" : [ "In", "vitro", "cytotoxicity", "of", "patient", "cells", "was", "assessed", "by", "using", "a", "4-day", "MTT", "conversion", "assay", ",", "as", "described", "before", "[", "8]", "." ]
}, {
  "sentence_tokens" : [ "Data", "were", "normalized", "to", "vehicle", "(", "DMSO", ")", "controls", "." ]
}, {
  "sentence_tokens" : [ "Western", "blot", "analysis", "." ]
}, {
  "sentence_tokens" : [ "Protein", "extracts", "(", "25", "mu", "g", ")", "were", "electrophoretically", "resolved", "on", "pre-cast", "SDS-polyacrylamide", "gels", "(", "anyKD", ",", "TGX", ",", "Bio-Rad", ",", "Veenendaal", ",", "The", "Netherlands", ")", "and", "transferred", "to", "nitrocellulose", "membranes", "." ]
}, {
  "sentence_tokens" : [ "Membranes", "were", "blocked", "with", "5", "%", "bovine", "serum", "albumin", "and", "subsequently", "probed", "with", "antibodies", "directed", "against", "total", "or", "phosphorylated", "ERK", ",", "MEK", ",", "ELK-1", ",", "Akt", ",", "or", "p70S6K", "(", "Cell", "Signaling", ",", "Danvers", ",", "MA", ",", "USA", ")", "." ]
}, {
  "sentence_tokens" : [ "Membranes", "were", "counterstained", "with", "IRDye", "(R)", "680/800", "conjugated", "secondary", "antibodies", "(", "Li/COR", ",", "Leusden", ",", "The", "Netherlands", ")", "and", "were", "scanned", "by", "an", "Odyssey", "imaging", "system", "(", "Li/COR", ")", "." ]
}, {
  "sentence_tokens" : [ "Membranes", "were", "re-probed", "with", "mouse", "monoclonal", "anti-beta-actin", "antibodies", "(", "Sigma-Aldrich", ",", "St.", "Louis", ",", "MO", ",", "USA", ")", "as", "loading", "control", "." ]
}, {
  "sentence_tokens" : [ "Fluorescence", "was", "quantified", "using", "the", "Odyssey", "3.0", "application", "software", "." ]
}, {
  "sentence_tokens" : [ "RAS", "activation", "." ]
}, {
  "sentence_tokens" : [ "RAS", "activation", "was", "analyzed", "using", "the", "RAS", "Activation", "Assay", "Kit", "(", "17-218", ",", "Merck-Millipore", ",", "Amsterdam", ",", "The", "Netherlands", ")", "." ]
}, {
  "sentence_tokens" : [ "Briefly", ",", "1", "x", "10", "cells", "were", "isolated", "and", "lysed", "with", "Mg", "Lysis", "Buffer", "(", "MLB", ")", ",", "and", "stored", "at", "-80", "degrees", "C", "until", "use", "." ]
}, {
  "sentence_tokens" : [ "GST", "fused", "RAF-1", "RBD", "bead", "slurry", "was", "added", "to", "the", "lysate", "and", "incubated", "for", "1", "hour", "at", "4", "degrees", "C", "while", "agitating", "." ]
}, {
  "sentence_tokens" : [ "Beads", "were", "isolated", "by", "centrifugation", "and", "washed", "with", "MLB", ",", "and", "precipitated", "protein", "was", "denatured", "with", "Laemmli", "buffer", "at", "95", "degrees", "C", "before", "immunoblotting", "." ]
}, {
  "sentence_tokens" : [ "As", "a", "positive", "control", ",", "total", "cell", "lysate", "was", "included", "in", "the", "immunoblotting", "procedure", "." ]
}, {
  "sentence_tokens" : [ "The", "provided", "RAS", "antibody", "(", "05-516", ",", "Merck-Millipore", ")", "was", "used", ",", "and", "GST", "(", "Cell", "Signaling", ")", "and", "beta-actin", "(", "Sigma-Aldrich", ")", "antibodies", "were", "used", "as", "loading", "controls", "for", "the", "beads", "and", "total", "protein", ",", "respectively", "." ]
}, {
  "sentence_tokens" : [ "Fluorescence", "was", "quantified", "using", "the", "Odyssey", "3.0", "application", "software", "." ]
}, {
  "sentence_tokens" : [ "Annexin-V/7-AAD", "apoptosis", "and", "cell", "cycle", "assays", "." ]
}, {
  "sentence_tokens" : [ "For", "assessment", "of", "early", "and", "late", "apoptosis", ",", "the", "PE", "Annexin-V", "Apoptosis", "Detection", "Kit", "(", "BD", "Pharmingen", ",", "Breda", ",", "The", "Netherlands", ")", "was", "used", "according", "to", "the", "manufacturer", "'s", "protocol", "." ]
}, {
  "sentence_tokens" : [ "Briefly", ",", "drug", "exposed", "cells", "were", "isolated", ",", "washed", "with", "PBS", "and", "re-suspended", "in", "binding", "buffer", "." ]
}, {
  "sentence_tokens" : [ "Cells", "were", "stained", "with", "PE", "Annexin", "V", "and/or", "7-AAD", "for", "15", "minutes", ",", "and", "sorted", "using", "fluorescence", "activated", "cell", "sorting", "(", "FACS", ")", "." ]
}, {
  "sentence_tokens" : [ "Cell", "cycle", "progression", "was", "assessed", "by", "permeabilization", "of", "isolated", "cells", "through", "hypotonic", "lysis", "." ]
}, {
  "sentence_tokens" : [ "Subsequently", ",", "RNAse", "treatment", "was", "performed", ",", "and", "DNA", "was", "stained", "using", "Propidium", "Iodide", ",", "after", "which", "FACS", "determined", "DNA", "content", "." ]
}, {
  "sentence_tokens" : [ "Data", "was", "analyzed", "using", "FlowJo", "software", "(", "FlowJo", ",", "Ashland", ",", "OR", ",", "USA", ")", "." ]
}, {
  "sentence_tokens" : [ "Gene", "expression", "data", "." ]
}, {
  "sentence_tokens" : [ "Recently", "published", "gene", "expression", "data", "(", "Affymetrix", "HU133plus2.0", ")", "for", "part", "of", "the", "t", "(", "4", ";", "11", ")", "patient", "samples", "was", "available", "(", "i.e.", "for", "6", "of", "9", "MEK", "inhibitor", "resistant", "RAS-wildtype", "samples", ",", "4", "of", "5", "sensitive", "RAS-wildtype", "samples", "and", "3", "of", "6", "RAS-mutant", "samples", ")", "[", "29", "]", "." ]
}, {
  "sentence_tokens" : [ "This", "data", "is", "available", "in", "GEO", "database19", "(", "accession", "number", "GSE19475", ")", "and", "was", "acquired", "as", "previously", "described", "[", "29", "]", "." ]
}, {
  "sentence_tokens" : [ "Tyrosine", "kinase", "receptor", "expression", "was", "derived", "from", "this", "dataset", ",", "using", "the", "following", "probe", "sets", ":", "206674_at", "(", "FLT3", ")", ",", "204406_at", "(", "VEGFR-1", ")", ",", "203934_at", "(", "VEGFR-2", ")", ",", "234379_at", "(", "VEGFR-3", ")", ",", "210973_s_at", "(", "FGFR-1", ")", ",", "208225_at", "(", "FGFR-2", ")", ",", "204380_s_at", "(", "FGFR-3", ")", ",", "204579_at", "(", "FGFR-4", ")", ",", "211551_at", "(", "EGFR", ")", ",", "210930_s_at", "(", "ERBB2", ")", ",", "226213_at", "(", "ERBB3", ")", ",", "214053_at", "(", "ERBB4", ")", ",", "205463_s_at", "(", "PDGFR-A", ")", ",", "217112_at", "(", "PDGFR-B", ")", ",", "204891_s_at", "(", "Lck", ")", "and", "213324_at", "(", "Src", ")", "." ]
}, {
  "sentence_tokens" : [ "Statistical", "analysis", "." ]
}, {
  "sentence_tokens" : [ "Statistical", "analyses", "were", "performed", "with", "SPSS", "Statistics", "version", "17.0", "(", "SPSS", "Inc.", "Chicago", ",", "IL", ",", "USA", ")", "." ]
}, {
  "sentence_tokens" : [ "All", "tests", "were", "two", "tailed", "and", "p-values", "<", "0.05", "were", "considered", "significant", "." ]
}, {
  "sentence_tokens" : [ "The", "effect", "of", "combining", "drugs", "(", "i.e.", "synergy", ",", "additivity", "or", "antagonism", ")", "was", "assessed", "using", "Berenbaums", "criteria", ",", "as", "previously", "described", "[", "9", ",", "10", "]", "." ]
}, {
  "sentence_tokens" : [ "Briefly", ",", "we", "calculated", "the", "Synergy", "Factor", "(", "F", ")", "with", "the", "formula", "F", "=", "(", "[", "Drug", "X", "]/[", "Drug", "X]", ")", "+", "(", "[", "Drug", "Y", "]/[", "Drug", "Y", "]", ")", "for", "a", "particular", "fractional", "effect", "." ]
}, {
  "sentence_tokens" : [ "If", "the", "drug", "combination", "results", "in", "F", "<", "1", ",", "this", "is", "considered", "synergy.Members", "of", "the", "INTERFANT-99", "study", "are", "as", "follows", ":", "M.", "Campbell", "(", "Programa", "Infantil", "Nacional", "de", "Drogas", "Atineoplasicas", "(", "PINDA", ")", ")", ",", "M.", "Felice", "(", "Argentina", ")", ",", "A.", "Ferster", "(", "Children", "'s", "Leukemia", "Group", "(", "CLCG", ")", ")", ",", "I.", "Hann", "and", "A.", "Vora", "(", "UK", "Children", "'s", "Cancer", "Study", "Group", "(", "UKCCSG", ")", ")", ",", "L.", "Hovi", "(", "Nordic", "Society", "of", "Paediatric", "Haematology", "and", "Oncology", "(", "NOPHO", ")", ")", ",", "G.", "Janka-Schaub", "(", "Cooperative", "Study", "Group", "for", "Treatment", "of", "ALL", "(", "COALL", ")", ")", ",", "C.K", "." ]
}, {
  "sentence_tokens" : [ "Li", "(", "Hong", "Kong", ")", ",", "G.", "Mann", "(", "Berlin-Frankfurt-Munster", "Group-Austria", "(", "BFM-A", ")", ")", ",", "T.", "LeBlanc", "(", "French", "ALL", "Group", "(", "FRALLE", ")", ")", ",", "R.", "Pieters", "(", "Dutch", "Childhood", "Oncology", "Group", "(", "DCOG", ")", ")", ",", "G.", "de", "Rossi", "and", "A.", "Biondi", "(", "Associazione", "Italiana", "Ematologia", "Oncologia", "Pediatrica", "(", "AIEOP", ")", ")", ",", "J.", "Rubnitz", "(", "St", "Jude", "Children", "'s", "Research", "Hospital", "(", "SJCRH", ")", ")", ",", "M.", "Schrappe", "(", "Berlin-Frankfurt-Munster", "Group-Germany", "(", "BFM-G", ")", ")", ",", "L.", "Silverman", "(", "Dana-Farber", "Cancer", "Institute", "(", "DFCI", ")", ")", ",", "J.", "Stary", "(", "Czech", "Paediatric", "Haematology", "(", "CPH", ")", ")", ",", "R.", "Suppiah", "(", "Australian", "and", "New", "Zealand", "Children", "'s", "Haematology", "and", "Oncology", "Group", "(", "ANZCHOG", ")", ")", ",", "T.", "Szczepanski", "(", "Polish", "Paediatric", "Leukemia", "and", "Lymphoma", "Study", "Group", "(", "PPLLSG", ")", ")", ",", "and", "M.", "Valsecchi", "and", "P.", "de", "Lorenzo", "(", "Trial", "Operating", "Center", "(", "CORS", ")", ")", "." ]
}, {
  "sentence_tokens" : [ "We", "thank", "P.", "Garrido", "Castro", "and", "D.", "Geerts", "for", "scientific", "input", "and", "reading", "the", "manuscript", "." ]
} ]